semaglutide tablets patent expiry in India opens up huge opportunity for generic drugmakers: Report @zydusuniverse Read more link in bio. #Semaglutide #DiabetesCare #ObesityTreatment #PharmaNews #NovoNordisk #DrugPatent What is the patent landscape

Nutritional Neuroscience, 25 (1), 6469

The standard criteria include: BMI of 30 kg/m or greater , or BMI of 27 kg/m or greater with at least one weight-related comorbidity (type 2 diabetes, hypertension, dyslipidemia, obstructive sleep apnea, or cardiovascular disease) Documentation of a structured dietary and exercise program lasting at least 3 to 6 months that did not produce clinically meaningful weight loss (typically defined as 5% or more of body weight) The prescriber is a physician, nurse practitioner, or physician assistant (telehealth prescribers are generally accepted if licensed in North Carolina) Step Therapy Rules Some BCBSNC plans enforce step therapy before Wegovy approval

Examinar los riesgos de las combinaciones de inhibidores de GLP-1RA-SGLT-2 debe ser parte de futuras investigaciones y toma de decisiones sobre el tratamiento

However, it is unclear whether this would be the case, and it has not yet been tested in the courts